amikacin has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charles, KD; Fayaz, SM; Kapfhammer, JP; Rajanikant, GK; Sinoy, S; Suvanish, VK | 1 |
| Benslama, A; Charra, B; Hachimi, A; Motaouakkil, S | 1 |
2 other study(ies) available for amikacin and Brain Ischemia
| Article | Year |
|---|---|
Amikacin Inhibits miR-497 Maturation and Exerts Post-ischemic Neuroprotection.
Topics: Amikacin; Animals; Base Sequence; Binding Sites; Brain Ischemia; Cell Line, Tumor; Glucose; Hippocampus; Humans; Mice; MicroRNAs; Molecular Dynamics Simulation; Neuroprotection; Neuroprotective Agents; Oxygen; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2017 |
[Intrathecal use of amikacin and colistin].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Amikacin; Brain Ischemia; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocephalus; Injections, Spinal; Male; Meningitis, Bacterial; Pseudomonas Infections; Shock, Septic; Surgical Wound Infection; Ventriculostomy | 2008 |